MetLife (NYSE:MET - Get Free Report) had its price target increased by equities research analysts at Morgan Stanley from $94.00 to $97.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an "overweight" rating on the financial services provider's stock. Morgan Stanley's price objective indicates a potential upside of 17.54% from the stock's current price.
MET has been the topic of a number of other research reports. Keefe, Bruyette & Woods lowered their target price on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a research note on Monday, August 11th. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a research note on Tuesday, July 8th. Weiss Ratings reissued a "buy (b)" rating on shares of MetLife in a research note on Saturday, September 27th. Cowen reissued a "buy" rating on shares of MetLife in a research note on Friday, August 22nd. Finally, Jefferies Financial Group upped their target price on shares of MetLife from $100.00 to $103.00 and gave the company a "buy" rating in a research note on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $94.91.
Read Our Latest Analysis on MetLife
MetLife Stock Performance
Shares of NYSE:MET traded up $0.18 on Tuesday, hitting $82.53. 369,572 shares of the company were exchanged, compared to its average volume of 3,396,191. The company's 50 day moving average price is $79.20 and its two-hundred day moving average price is $78.14. MetLife has a one year low of $65.21 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market capitalization of $54.88 billion, a price-to-earnings ratio of 14.01, a PEG ratio of 0.74 and a beta of 0.86.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $18.58 billion. During the same quarter in the previous year, the firm posted $2.28 EPS. The business's revenue for the quarter was down 2.7% compared to the same quarter last year. Research analysts expect that MetLife will post 9.65 earnings per share for the current year.
Institutional Trading of MetLife
Large investors have recently added to or reduced their stakes in the company. North Capital Inc. bought a new stake in MetLife during the first quarter worth about $26,000. Quaker Wealth Management LLC grew its stake in MetLife by 198.2% during the second quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider's stock worth $27,000 after buying an additional 672 shares during the last quarter. Motco grew its stake in MetLife by 105.5% during the first quarter. Motco now owns 413 shares of the financial services provider's stock worth $33,000 after buying an additional 212 shares during the last quarter. Evolution Wealth Management Inc. bought a new stake in MetLife during the second quarter worth about $35,000. Finally, MTM Investment Management LLC bought a new stake in MetLife during the second quarter worth about $37,000. 94.99% of the stock is owned by institutional investors.
About MetLife
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.